Quick Answer
Galmed Pharmaceuticals Ltd. reported Total Assets of $18.63 million for fiscal year 2025.
Galmed Pharmaceuticals Ltd. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $18.63M | +0.7% |
| 2024 | $18.50M | +11.3% |
| 2023 | $16.63M | +0.4% |
| 2022 | $16.56M | -54.8% |
| 2021 | $36.60M | -30.1% |
| 2020 | $52.38M | -32.1% |
| 2019 | $77.14M | -14.9% |
| 2018 | $90.60M | +361.2% |
| 2017 | $19.64M | +19.4% |
| 2016 | $16.45M | -32.2% |
| 2015 | $24.26M | -26.3% |
| 2014 | $32.92M | +19734.3% |
| 2013 | $166.0K | — |
- Galmed Pharmaceuticals Ltd. showed an increase of +0.7% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Galmed Pharmaceuticals Ltd.’s total assets has grown by 11121.1% (from $166.0 thousand to $18.63 million).
- The most recent figure is from Galmed Pharmaceuticals Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: